Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
Gossamer Bio's 1-for-80 reverse stock split became effective at 11:59 p.m. ET on September 10, 2026, with split-adjusted shares trading on the Nasdaq Global Select Market under GOSS at the September 11 open under a new CUSIP of 38341P 201. The split is intended to help the clinical-stage biopharmaceutical company regain compliance with Nasdaq's minimum bid price requirement, which requires a closing bid of at least $1.00 for 10 consecutive business days before the October 5, 2026 compliance date.
Key figures
- New cusip
- 38341P 201
- Effective time
- 11:59 p.m. ET September 10, 2026
- Reverse split ratio
- 1-for-80
- Nasdaq compliance date
- October 5, 2026
- Compliance days required
- 10 consecutive business days
- Split adjusted trading start
- September 11, 2026
- Minimum bid price requirement
- $1.00
- Authorized common shares after
- 50000000
- Authorized common shares before
- 4000000000
- Authorized total capital stock after
- 120000000
- Authorized total capital stock before
- 4070000000
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.